Month: July 2023

Ad hoc announcement pursuant to Art. 53 LR Feintool wins an important new customer as a supplier of rotors and stators. The multi-year contract for a renowned American OEM has a lifetime volume in the triple-digit million euro range. For the first time, the innovative Glulock Multidot (MD) bonding technology will be used in high volume production for the main drives of electric cars. Feintool has been awarded a multi-year contract by a renowned American original equipment manufacturer (OEM). The contract involves supplying stators and rotors for the main drive of e-cars over a six-year period and has a lifetime volume valued in the three-digit million euro range. For the first time, the innovative and patented Glulock MD bonding technology will be used in high volume production to manufacture these components. Winning this significant...

Harvest volumes Q2 2023 (1)Farming Norway 61.5 thousand tonnesFarming Scotland 18.0 thousand tonnesFarming Chile 14.0 thousand tonnesFarming Canada 9.5 thousand tonnesFarming Ireland 1.5 thousand tonnesFarming Faroes 3.0 thousand tonnesFarming Iceland (Arctic Fish) 0.1 thousand tonnesTotal 107.5 thousand tonnes   In connection with the presentation of the Q1 2023 results, Mowi ASA guided a total harvest volume of 104.5 thousand tonnes (GWE) for Q2 2023. Note:(1) The harvest volumes are provided in gutted weight equivalents (GWE). Additional information Operational EBIT for the Group was approximately EUR 300 million in Q2 2023 (EUR 320 million in Q2 2022). EUR/NOK for the quarter was 11.66. Total Operational EBIT per kg through the value chain was approximately as follows:Norway EUR 3.35Scotland EUR 2.30Chile EUR 1.80Canada EUR 1.30Ireland EUR 1.40Faroes EUR 4.60Operational...

14 July 2023 – Media Release Ad hoc announcement pursuant to Article 53 of SIX Exchange Regulation Listing Rules ONE swiss bank SA H1 2023 financial results (true and fair view) H1 2023 Financial Statements can be downloaded here.All documents are available on oneswissbank.com in the “Investor relations” section. H1 2023 highlightsGrégoire Pennone, CEO, ONE swiss bank “Following the successful completion of our turnaround last year, we’re pleased to share our latest financial achievements with you today. Earnings before interest, taxes, depreciation and amortisation (EBITDA) in the first six months of the year increased by a substantial 528%, i.e. by CHF 6.73 million, demonstrating our continued focus on profitability. We’ve also seen a significant increase in net profit to CHF 5.81 million, which was CHF 6.66 million higher than in...

COMPANY ANNOUNCEMENT NO. 13-202314 July 2023, Copenhagen, DenmarkOn 14 July 2023, FLSmidth Cement sold its Advanced Filtration Technologies (AFT) filter media business to Micronics, a leading global provider of industrial filtration solutions. The sale is effective immediately and includes all related assets, including intellectual property, technology, employees and customer contracts. The divestment of the AFT business is part of FLSmidth Cement’s pure play strategy, which includes focusing the cement product portfolio on the core technologies required for the green transition in the cement industry. “FLSmidth’s AFT filter media business has grown to become one of the leading manufacturers of industrial filter bags, serving clients worldwide in among other the cement, lime, minerals, metals and power industries. FLSmidth appreciates...

BERKELEY, Calif., July 13, 2023 (GLOBE NEWSWIRE) — Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the pricing of an upsized underwritten public offering of 19,230,769 shares of its common stock at a public offering price of $6.50 per share. All of the common stock to be sold in the offering will be offered by Caribou. The gross proceeds to Caribou from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $125 million, excluding any exercise of the underwriters’ option. Caribou has granted the underwriters a 30-day option to purchase up to an additional 2,884,615 shares of its common stock at the public offering price per share, less underwriting discounts and commissions. The...

SAN MATEO, Calif., July 13, 2023 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (“Sagimet”) (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic pathways, today announced the pricing of its upsized initial public offering of 5,312,500 shares of its Series A common stock at a public offering price of $16.00 per share. All of the shares of Series A common stock are being offered by Sagimet. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Sagimet, are expected to be $85.0 million. Sagimet’s Series A common stock is expected to begin trading on the Nasdaq Global Market on July 14, 2023 under the ticker symbol “SGMT.” The offering is expected to close on July 18, 2023, subject to the...